Developer docs
API playgroundTry for free, no card

Search company profiles

Ascend Partners

Full company profile

uuid00022vc

Namestring
Ascend Partners
Legal namestring
Ascend Partners
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Ascend Partners is a healthcare-focused private equity partnership founded in 2019 and headquartered at 300 Park Avenue in New York City. The firm invests in physician practice management companies, value-based care enablement platforms, and healthcare IT businesses that serve underserved and vulnerable patient populations, with a particular emphasis on Asian American communities and Medicare/Medicaid beneficiaries. The firm's investment model combines majority-stake equity capital with operational support delivered through its affiliated management services organization, CareAbout, which provides clinical quality improvement, multi-site practice management, data analytics, compliance, and population health management to portfolio companies. Ascend manages two closed private equity funds: Fund I at $570 million (closed December 2021, fully deployed across eight platform investments) and Fund II at $791 million (closed February 2026 above its $700M target), for combined committed capital of approximately $1.36 billion. The firm is led by co-founders In Seon Hwang (former global head of Healthcare at Warburg Pincus) and Dr. Richard Park (founder and former CEO of CityMD), supported by a team of approximately twenty full-time professionals including twelve investment professionals drawn from Warburg Pincus, Goldman Sachs, Onex Partners, CD&R, Cain Brothers, Blackstone, BlackRock, Oak Street Health, and H.I.G. Capital.

Ascend's go-to-market is enterprise field sales targeting both investment management Limited Partners (public and private pension funds, foundations, endowments, consultants, family offices, and funds of funds) and healthcare services management teams in fragmented markets. The firm's revenue model follows standard private equity economics, generating recurring management fees on committed capital (and stepped-down net invested capital post-investment period) plus performance-based carried interest on realizations above preferred return. Marketing and fundraising channels include a corporate website, LinkedIn presence, industry conferences, and engagement of institutional placement agents (Credit Suisse for Fund I, William Blair for Fund II) and strategic communications advisors (Joele Frank, Wilkinson Brimmer Katcher). Ascend's current portfolio spans nine platform companies including Unison Therapy Services, Seoul Medical Group, Elation Health, Medical Specialists of the Palm Beaches, Allied Physicians Group, Consensus Health, Ilumed, Essen Health Care, and Rendr, with selective co-investment from partners such as Kain Capital. Geographic exposure includes New York, New Jersey, Florida, California, Georgia, Hawaii, Virginia, and Washington, reflecting both organic platform expansion and tuck-in mergers such as the Rendr-Excelsior combination (2022) and the Seoul Medical Group-Korean American Medical Group combination (2025).

Short descriptiontext

Ascend Partners is a New York-based, healthcare-focused private equity firm founded in 2019 that invests in physician practice management, value-based care enablement, and healthcare IT companies serving underserved populations, managing approximately $1.36 billion across two funds.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare private equity, physician practice management, value-based care investment, healthcare services investment, underserved community healthcare
Industry2 codes
PRIMARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
SECONDARYHLAFAAAO
Hospital Shared Services, GPOs & System Support Organizations
Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Healthcare-focused Private Equity
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Fund Management - Management Fees
TypeManaged Services
Description

Standard private equity fund management model with management fees charged on committed capital under management. Fund I closed at $570 million hard cap; Fund II closed at $791 million.

ascendpartners.com
2Fund Management - Carried Interest
TypeManaged Services
Description

Performance-based carried interest from fund investments when portfolio companies achieve returns above preferred return thresholds.

ascendpartners.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Private equity fund investment for institutional Limited Partners
ModelOtherBilling cadenceMulti-year contract
Notes

Fund management fees and carried interest terms are standard for institutional private equity and not publicly disclosed.

ascendpartners.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Ascend Partners is a healthcare-focused private equity firm that acquires majority stakes in physician practice management companies, value-based care enablement platforms, and healthcare IT companies serving underserved populations. The firm manages two investment funds (Fund I at $570 million, Fund II at $791 million) and provides portfolio companies with operational support through its affiliated management services organization CareAbout, which delivers clinical quality improvement, multi-site practice management, data analytics, value-based care delivery, and population health management services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • CityMD grew from single-site startup to nearly $500 million in revenues in 2019 under Dr. Park's leadership
+3 more records
Product overview1 text field

Ascend Partners is a healthcare-focused private equity firm (not a technology product company). The firm's core offering is investment capital combined with operational support through its management services organization, CareAbout. CareAbout provides infrastructure, technology, compliance, and administrative services to portfolio companies. The firm manages two investment funds (Fund I at $570M and Fund II at $791M) that invest in physician practice management companies, value-based care enablement platforms, and healthcare IT companies serving underserved populations.

Product and service3 records
1CareAbout Management Services Organization
CategoryManagement Services Organization (MSO)
Description

CareAbout is a management services organization (MSO) affiliated with Ascend Partners that provides operational infrastructure, clinical quality improvement, finance, IT, compliance, and administrative support to Ascend's portfolio companies. It is built to help physicians deliver quality-focused, consistent care and provides full-time operating executives with deep healthcare delivery expertise.

2Ascend Capital Partners Fund I
CategoryPrivate Equity Fund
Description

Ascend's inaugural private equity fund closed at $570 million hard cap in December 2021, fully deployed across eight platform investments in physician practice management, value-based care enablement, and healthcare IT serving underserved populations. Limited Partners include public and private pension funds, foundations, financial institutions, and family offices.

3Ascend Capital Partners Fund II
CategoryPrivate Equity Fund
Description

Ascend's second private equity fund closed at $791 million in February 2026, exceeding its $700 million target. Fund II invests across physician and provider services, value-based care enablement companies, and healthcare IT. Limited Partners include existing and new public/private pension funds, foundations, endowments, consultants, family offices, and funds of funds.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMinorTypeOthersAnnounced on2026-03-13
Description

Strategic communications advisor for Fund II announcement and ongoing media relations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-31
Description

CareAbout partnered with Allied Physicians Group and Adjuvant.Health to improve healthcare delivery and clinical quality through management services.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-12-05
Description

CareAbout partnered with MSPB (Medical Specialists of the Palm Beaches) to expand primary care services and improve patient care management and delivery.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-12-09
Description

Management services organization (MSO) affiliated with Ascend that provides operational support to portfolio companies. CareAbout employs full-time operating executives with deep healthcare delivery expertise including quality improvement, multi-site practice management, data analytics, value-based care delivery, and population health management.

Strategic tierMinorTypeOthersAnnounced on2021-12-09
Description

Served as legal counsel to Ascend for Fund I and Fund II closings.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Long-standing healthcare-focused private equity firm that invests in healthcare services and technology businesses. Directly comparable to Ascend as a specialist healthcare PE manager with operating support capabilities and a similar sub-sector focus on physician services and value-based care.

TypeDirect peer
Description

Chicago-based PE firm exclusively focused on healthcare services, including physician practice management, behavioral health, and value-based care. Closely comparable to Ascend in thesis, fund size, and operating-partner model.

TypeDirect peer
Description

Healthcare-focused private equity firm with significant investments in physician services, value-based care enablement, and healthcare IT. Comparable to Ascend in sub-sector focus and in providing operational/strategic support to portfolio companies.

TypeDirect peer
Description

Middle-market healthcare-focused PE firm investing in physician services, dental, and healthcare technology. Directly comparable to Ascend as a smaller specialist healthcare PE manager with a focus on fragmented provider markets.

TypeDirect peer
Description

Healthcare-focused PE firm investing in pharmaceutical services, medical products, and healthcare services businesses. Comparable to Ascend as a specialist healthcare PE manager with similar fund-size vintage profile.

TypeDirect peer
Description

Healthcare-focused private equity firm specializing in healthcare services, including physician groups and specialty providers. Directly comparable to Ascend and an actual co-investor with Ascend in portfolio companies such as Rendr and Excelsior.

TypeBroad incumbent
Description

Global alternative asset manager with a dedicated TPG Healthcare practice investing across provider services, healthcare IT, and life sciences. Comparable to Ascend in healthcare investing thesis but at a much larger scale and broader mandate.

TypeBroad incumbent
Description

Global private investment firm with a dedicated Bain Capital Life Sciences and Bain Capital Healthcare practice. Comparable to Ascend in healthcare services and technology investing, but as a much larger, more diversified incumbent.

TypeBroad incumbent
Description

Global growth-oriented PE firm with a long-standing healthcare practice covering providers, services, and technology. Comparable to Ascend as a healthcare PE investor, and notably the prior employer of Ascend co-founder In Seon Hwang.

10KKR
TypeBroad incumbent
Description

Global alternative asset manager with a dedicated healthcare strategy spanning provider services, healthcare IT, and life sciences. Comparable to Ascend as a healthcare PE investor but operating across a much broader set of strategies and asset classes.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles20 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ascend Partners

Healthcare-focused Private Equityascendpartners.com

Ascend Partners is a New York-based, healthcare-focused private equity firm founded in 2019 that invests in physician practice management, value-based care enablement, and healthcare IT companies serving underserved populations, managing approximately $1.36 billion across two funds.

What Ascend Partners does

Ascend Partners is a healthcare-focused private equity partnership founded in 2019 and headquartered at 300 Park Avenue in New York City. The firm invests in physician practice management companies, value-based care enablement platforms, and healthcare IT businesses that serve underserved and vulnerable patient populations, with a particular emphasis on Asian American communities and Medicare/Medicaid beneficiaries. The firm's investment model combines majority-stake equity capital with operational support delivered through its affiliated management services organization, CareAbout, which provides clinical quality improvement, multi-site practice management, data analytics, compliance, and population health management to portfolio companies. Ascend manages two closed private equity funds: Fund I at $570 million (closed December 2021, fully deployed across eight platform investments) and Fund II at $791 million (closed February 2026 above its $700M target), for combined committed capital of approximately $1.36 billion. The firm is led by co-founders In Seon Hwang (former global head of Healthcare at Warburg Pincus) and Dr. Richard Park (founder and former CEO of CityMD), supported by a team of approximately twenty full-time professionals including twelve investment professionals drawn from Warburg Pincus, Goldman Sachs, Onex Partners, CD&R, Cain Brothers, Blackstone, BlackRock, Oak Street Health, and H.I.G. Capital.

Ascend's go-to-market is enterprise field sales targeting both investment management Limited Partners (public and private pension funds, foundations, endowments, consultants, family offices, and funds of funds) and healthcare services management teams in fragmented markets. The firm's revenue model follows standard private equity economics, generating recurring management fees on committed capital (and stepped-down net invested capital post-investment period) plus performance-based carried interest on realizations above preferred return. Marketing and fundraising channels include a corporate website, LinkedIn presence, industry conferences, and engagement of institutional placement agents (Credit Suisse for Fund I, William Blair for Fund II) and strategic communications advisors (Joele Frank, Wilkinson Brimmer Katcher). Ascend's current portfolio spans nine platform companies including Unison Therapy Services, Seoul Medical Group, Elation Health, Medical Specialists of the Palm Beaches, Allied Physicians Group, Consensus Health, Ilumed, Essen Health Care, and Rendr, with selective co-investment from partners such as Kain Capital. Geographic exposure includes New York, New Jersey, Florida, California, Georgia, Hawaii, Virginia, and Washington, reflecting both organic platform expansion and tuck-in mergers such as the Rendr-Excelsior combination (2022) and the Seoul Medical Group-Korean American Medical Group combination (2025).

Ascend Partners firmographics

Firmographics
Name
Ascend Partners
Legal name
Ascend Partners
Website
https://ascendpartners.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Ascend Partners is a New York-based, healthcare-focused private equity firm founded in 2019 that invests in physician practice management, value-based care enablement, and healthcare IT companies serving underserved populations, managing approximately $1.36 billion across two funds.
Ownership category
akta.pro rank

Ascend Partners industry classification

Industry
Product category
Healthcare-focused Private Equity
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Security Brokers, Dealers & Flotation Companies (6211)
akta.pro industry
PRIMARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
SECONDARYHLAFAAAO
Hospital Shared Services, GPOs & System Support Organizations
Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems

Keywords

  • Healthcare private equity
  • Physician practice management
  • Value-based care investment
  • Healthcare services investment
  • Underserved community healthcare

Where Ascend Partners is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Ascend Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Fund Management - Management Fees: Standard private equity fund management model with management fees charged on committed capital under management. Fund I closed at $570 million hard cap; Fund II closed at $791 million.
  2. Fund Management - Carried Interest: Performance-based carried interest from fund investments when portfolio companies achieve returns above preferred return thresholds.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractPrivate equity fund investment for institutional Limited Partners

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Ascend Partners product offering

Product offering

Core offering

Ascend Partners is a healthcare-focused private equity firm that acquires majority stakes in physician practice management companies, value-based care enablement platforms, and healthcare IT companies serving underserved populations. The firm manages two investment funds (Fund I at $570 million, Fund II at $791 million) and provides portfolio companies with operational support through its affiliated management services organization CareAbout, which delivers clinical quality improvement, multi-site practice management, data analytics, value-based care delivery, and population health management services.

Product overview

Ascend Partners is a healthcare-focused private equity firm (not a technology product company). The firm's core offering is investment capital combined with operational support through its management services organization, CareAbout. CareAbout provides infrastructure, technology, compliance, and administrative services to portfolio companies. The firm manages two investment funds (Fund I at $570M and Fund II at $791M) that invest in physician practice management companies, value-based care enablement platforms, and healthcare IT companies serving underserved populations.

Differentiator

Problem solved

Functional benefit

Products and services

  • CareAbout Management Services Organization CareAbout is a management services organization (MSO) affiliated with Ascend Partners that provides operational infrastructure, clinical quality improvement, finance, IT, compliance, and administrative support to Ascend's portfolio companies. It is built to help physicians deliver quality-focused, consistent care and provides full-time operating executives with deep healthcare delivery expertise.
  • Ascend Capital Partners Fund I Ascend's inaugural private equity fund closed at $570 million hard cap in December 2021, fully deployed across eight platform investments in physician practice management, value-based care enablement, and healthcare IT serving underserved populations. Limited Partners include public and private pension funds, foundations, financial institutions, and family offices.
  • Ascend Capital Partners Fund II Ascend's second private equity fund closed at $791 million in February 2026, exceeding its $700 million target. Fund II invests across physician and provider services, value-based care enablement companies, and healthcare IT. Limited Partners include existing and new public/private pension funds, foundations, endowments, consultants, family offices, and funds of funds.

Quantifiable outcome

  • CityMD grew from single-site startup to nearly $500 million in revenues in 2019 under Dr. Park's leadership
  • +3 more outcomes

Companies that use Ascend Partners

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Ascend Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Ascend Partners partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor and core.

  • Joele Frank, Wilkinson Brimmer KatcherminorOthers · 13 March 2026Strategic communications advisor for Fund II announcement and ongoing media relations.
  • CareAbout (for Allied Physicians Group)coreStrategic or Co-development Partner · 31 January 2023CareAbout partnered with Allied Physicians Group and Adjuvant.Health to improve healthcare delivery and clinical quality through management services.
  • CareAbout (for MSPB)coreStrategic or Co-development Partner · 5 December 2022CareAbout partnered with MSPB (Medical Specialists of the Palm Beaches) to expand primary care services and improve patient care management and delivery.
  • CareAboutcoreStrategic or Co-development Partner · 9 December 2021Management services organization (MSO) affiliated with Ascend that provides operational support to portfolio companies. CareAbout employs full-time operating executives with deep healthcare delivery expertise including quality improvement, multi-site practice management, data analytics, value-based care delivery, and population health management.
  • Kirkland & EllisminorOthers · 9 December 2021Served as legal counsel to Ascend for Fund I and Fund II closings.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Ascend Partners competitors and assessment

Company assessment

Direct peers

  • Welsh, Carson, Anderson & Stowe: Long-standing healthcare-focused private equity firm that invests in healthcare services and technology businesses. Directly comparable to Ascend as a specialist healthcare PE manager with operating support capabilities and a similar sub-sector focus on physician services and value-based care.
  • Linden Capital Partners: Chicago-based PE firm exclusively focused on healthcare services, including physician practice management, behavioral health, and value-based care. Closely comparable to Ascend in thesis, fund size, and operating-partner model.
  • New Mountain Capital: Healthcare-focused private equity firm with significant investments in physician services, value-based care enablement, and healthcare IT. Comparable to Ascend in sub-sector focus and in providing operational/strategic support to portfolio companies.
  • Enhanced Healthcare Partners: Middle-market healthcare-focused PE firm investing in physician services, dental, and healthcare technology. Directly comparable to Ascend as a smaller specialist healthcare PE manager with a focus on fragmented provider markets.
  • Avista Capital Partners: Healthcare-focused PE firm investing in pharmaceutical services, medical products, and healthcare services businesses. Comparable to Ascend as a specialist healthcare PE manager with similar fund-size vintage profile.
  • Kain Capital: Healthcare-focused private equity firm specializing in healthcare services, including physician groups and specialty providers. Directly comparable to Ascend and an actual co-investor with Ascend in portfolio companies such as Rendr and Excelsior.

Broad incumbents

  • TPG Capital: Global alternative asset manager with a dedicated TPG Healthcare practice investing across provider services, healthcare IT, and life sciences. Comparable to Ascend in healthcare investing thesis but at a much larger scale and broader mandate.
  • Bain Capital: Global private investment firm with a dedicated Bain Capital Life Sciences and Bain Capital Healthcare practice. Comparable to Ascend in healthcare services and technology investing, but as a much larger, more diversified incumbent.
  • Warburg Pincus: Global growth-oriented PE firm with a long-standing healthcare practice covering providers, services, and technology. Comparable to Ascend as a healthcare PE investor, and notably the prior employer of Ascend co-founder In Seon Hwang.
  • KKR: Global alternative asset manager with a dedicated healthcare strategy spanning provider services, healthcare IT, and life sciences. Comparable to Ascend as a healthcare PE investor but operating across a much broader set of strategies and asset classes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Ascend Partners social profiles

Digital presence

Ascend Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ascend Partners leadership team

Management profile

Number of profiles

Profiles20 records

Ascend Partners subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Ascend Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ascend Partners M&A and investment

M&A and investment

M&A2 records

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ascend Partners

What does Ascend Partners do?

Ascend Partners is a healthcare-focused private equity firm that acquires majority stakes in physician practice management companies, value-based care enablement platforms, and healthcare IT companies serving underserved populations. The firm manages two investment funds (Fund I at $570 million, Fund II at $791 million) and provides portfolio companies with operational support through its affiliated management services organization CareAbout, which delivers clinical quality improvement, multi-site practice management, data analytics, value-based care delivery, and population health management services.

Is Ascend Partners a public or private company?

Ascend Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Ascend Partners founded?

Ascend Partners was founded in 2019. It employs 11 to 50 people.

Where is Ascend Partners based?

Ascend Partners is headquartered in New York, United States, in the North America region.

How does Ascend Partners make money?

Two revenue lines are on record. Fund Management - Management Fees are the primary driver. The others are fund Management - Carried Interest.

Who are Ascend Partners's main competitors?

Direct peers on record are Welsh, Carson, Anderson & Stowe, Linden Capital Partners, New Mountain Capital, Enhanced Healthcare Partners, Avista Capital Partners and Kain Capital. Broad incumbents are TPG Capital, Bain Capital, Warburg Pincus and KKR.

Does Ascend Partners have an API?

No public API is recorded for Ascend Partners.

What industry is Ascend Partners in?

Ascend Partners's product category is Healthcare-focused Private Equity. Its primary akta.pro industry code is FSANAJAI, Healthcare Access & Life Sciences Impact Funds, with a secondary code of HLAFAAAO, Hospital Shared Services, GPOs & System Support Organizations. Its NAICS code is 523940 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Venture Capital Access OnlineAscend Capital Partners Closes Oversubscribed Fund II Above Target at $791 MillionAscend Capital Partners, a healthcare-focused private equity firm, announced the final close of its Fund II at $791 million in total commitments, surpassing its initial $700 million target. The fund will invest in physician and provider services, value-based care enablement companies, and healthcare IT, building on the firm's inaugural $570 million fund that is now fully deployed. Ascend Fund II is already actively deploying capital, with investments made in Seoul Medical Group and Unison Therapy Services.IMPACT ENGINEHealth Equity Portfolio — IMPACT ENGINEThe article presents a curated portfolio of companies and investment funds focused on health equity, digital health, and sustainable healthcare solutions. It lists various entities including private equity firms like Ascend Partners and Blume Equity, alongside venture-backed startups such as Alcanza Clinical Research, CancerIQ, and NephroPlus. The content highlights the strategic investments made to improve accessibility, affordability, and quality of care for diverse and underserved populations.YahooAscend Partners Announces Strategic Investment with Achieve Partners to Scale GrowthAscend Partners announced a strategic investment from Achieve Partners to accelerate growth and innovation. The funding will expand Ascend's offerings and invest in its team, aligning with its mission to future-proof clients' financial systems. The partnership aims to scale while maintaining excellence in the OneStream ecosystem.PR NewswireMedical Specialists of the Palm Beaches (MSPB) has acquired Palm Beach Digestive Associates (PBDA) with support from Ascend Partners and CareAboutMedical Specialists of the Palm Beaches (MSPB) has acquired Palm Beach Digestive Associates (PBDA), integrating it as its new Gastrointestinal Division. This transaction marks MSPB's first acquisition since receiving an equity investment from Ascend Partners and CareAbout in December 2022.PR NewswireSouth Florida Primary-Care and Multi-Specialty Physician Group Practice Receives Private Equity InvestmentMedical Specialists of the Palm Beaches (MSPB), a primary care-focused multi-specialty physician group practice serving Palm Beach and Broward counties in Florida, has received an equity investment from healthcare-focused private equity firm Ascend Capital Partners and management company CareAbout. Post-investment, MSPB plans to expand its footprint and value-based care offerings, enhance patient education efforts, and invest in additional clinical specialty services across South Florida. Founded in 1995, MSPB currently operates more than 85 providers across 25+ offices offering primary care, cardiology, neurology, hematology/oncology, concierge medicine, and laboratory services.WsjAscend Partners Raises $570 Million for Debut Healthcare FundAscend Partners raised $570 million for its first healthcare fund, Ascend Capital Partners Fund I, which targets companies serving underserved communities. The fund, co-founded by Dr. Richard Park and In Seon Hwang, exceeded its initial $300 million target.Business Wire BlogAscend Partners Announces Closing of $570 Million Inaugural Fund at Hard CapAscend Partners closed its inaugural fund, Ascend Capital Partners Fund I, at a $570 million hard cap. The fund is oversubscribed and targets patient-centric healthcare companies serving underserved communities. The firm plans to invest in the fragmented physician practice management market.